Production Method 1

17301-94-9

5911-04-6

871-83-0

Reaction Conditions

1.1 Reagents: Hydrogen Catalysts: Alumina ,  Platinum ,  Silica ,  Phosphoric acid ;  60 min, 1 atm, 330 °C

Reference

Microwave synthesis of SAPO-11 materials for long chain n-alkanes hydroisomerization: Effect of physical parameters and chemical gel composition

Bertolo, R.; et al, Applied Catalysis, 2017, 542, 28-37

Production Method 2

17301-94-9

15869-85-9

5911-04-6

871-83-0

Reaction Conditions

1.1 Reagents: Hydrogen Catalysts: Alumina ,  Platinum ,  Silica ,  Phosphoric acid ;  60 min, 1 atm, 330 °C

Reference

Microwave synthesis of SAPO-11 materials for long chain n-alkanes hydroisomerization: Effect of physical parameters and chemical gel composition

Bertolo, R.; et al, Applied Catalysis, 2017, 542, 28-37

Production Method 3

17301-94-9

15869-85-9

5911-04-6

871-83-0

Reaction Conditions

1.1 Catalysts: Sodium oxide ,  Palladium ,  Silica ,  1H-Imidazolium, 1,3-dicyclohexyl-, hydroxide (1:1) Solvents: Water ;  3 h, 482 °C

Reference

Synthesis, Physicochemical Characterization, and Catalytic Evaluation of Fe3+-Containing SSZ-70 Zeolite

Lew, Christopher M. ; et al, ACS Catalysis, 2022, 12(11), 6464-6477

4-Methylnonane Preparation Products

• Nonane, 5-methyl- (15869-85-9)
• 4-Methylnonane (17301-94-9)
• 3-Methylnonane (5911-04-6)
• 2-Methylnonane (871-83-0)

• 1. Selective dimerisation of α-olefins using tungsten-based initiators
  Martin J. Hanton,Louisa Daubney,Tomas Lebl,Stacey Polas,David M. Smith,Alex Willemse Dalton Trans. 2010 39 7025
• 2. Hydrodeoxygenation reactivity of the carbonyl group and carboxyl group and their interaction: taking 2-pentanone, valeric acid, and levulinic acid as examples
  Xi Xi,Ye Yang,Hualiang An,Xinqiang Zhao,Yanji Wang Sustainable Energy Fuels 2022 6 1780
• 3. Probing the surface of nanosheet H-ZSM-5 with FTIR spectroscopy
  Bj?rn-Tore L?nstad Bleken,Lorenzo Mino,Filippo Giordanino,Pablo Beato,Stian Svelle,Karl Petter Lillerud,Silvia Bordiga Phys. Chem. Chem. Phys. 2013 15 13363
• 4. New zeolite Al-COE-4: reaching highly shape-selective catalytic performance through interlayer expansion
  Bilge Yilmaz,Ulrich Müller,Mathias Feyen,Haiyan Zhang,Feng-Shou Xiao,Trees De Baerdemaeker,Bart Tijsebaert,Pierre Jacobs,Dirk De Vos,Weiping Zhang,Xinhe Bao,Hiroyuki Imai,Takashi Tatsumi,Hermann Gies Chem. Commun. 2012 48 11549
• 5. Hydroisomerization and hydrocracking activity enhancement of a hierarchical ZSM-5 zeolite catalyst via atomic layer deposition of aluminium
  Sreeprasanth Pulinthanathu Sree,Jolien Dendooven,Pieter C. M. M. Magusin,Karine Thomas,Jean-Pierre Gilson,Francis Taulelle,Christophe Detavernier,Johan A. Martens Catal. Sci. Technol. 2016 6 6177

• Solvents and Organic Chemicals Organic Compounds Hydrocarbons Saturated hydrocarbons Branched alkanes
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons Saturated hydrocarbons Alkanes Branched alkanes
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons
• Other Chemical Reagents

Research Brief on 17301-94-9 and 4-Methylnonane: Latest Advances in Chemical and Biomedical Applications

The chemical compound with the CAS number 17301-94-9 and the product name 4-Methylnonane has recently garnered significant attention in the fields of chemical synthesis and biomedical research. This research brief aims to provide an overview of the latest findings related to these substances, focusing on their synthesis, properties, and potential applications in drug development and other biomedical areas.

Recent studies have explored the synthesis and characterization of 4-Methylnonane, a branched alkane with potential applications as a solvent or intermediate in pharmaceutical manufacturing. Researchers have investigated its physicochemical properties, including boiling point, solubility, and stability, which are critical for its use in various chemical processes. Additionally, the compound's low toxicity profile makes it a candidate for further exploration in drug delivery systems.

In the context of CAS 17301-94-9, recent literature highlights its role as a key intermediate in the synthesis of more complex organic molecules. Its unique structural features have been leveraged in the development of novel catalysts and ligands, which are essential for asymmetric synthesis and other advanced chemical transformations. These advancements have implications for the production of enantiomerically pure pharmaceuticals, a growing area of interest in the industry.

One notable study published in 2023 demonstrated the use of 4-Methylnonane as a reaction medium in the synthesis of bioactive compounds. The research showed that the compound's inert nature and ability to dissolve a wide range of organic molecules make it an excellent candidate for green chemistry applications. This aligns with the broader industry trend toward sustainable and environmentally friendly chemical processes.

Further investigations into the biomedical applications of these compounds are ongoing. Preliminary data suggest that derivatives of 17301-94-9 may exhibit antimicrobial or anti-inflammatory properties, though more in vitro and in vivo studies are needed to confirm these effects. The potential for these compounds to serve as scaffolds for new drug candidates is an exciting avenue for future research.

In conclusion, the latest research on 17301-94-9 and 4-Methylnonane underscores their versatility and potential in both chemical and biomedical fields. Continued exploration of their properties and applications could lead to significant advancements in drug development and sustainable chemistry. Researchers are encouraged to further investigate these compounds to unlock their full potential.

• 68551-20-2(Alkanes, C13-16-iso-)
• 871-83-0(2-Methylnonane)
• 592-13-2(2,5-Dimethylhexane)
• 111-01-3(Squalane)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)